Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by MartyDon May 02, 2024 8:58am
152 Views
Post# 36019114

I feel good

I feel goodI know when my team comes to me and asks me to acquire a second tool, they like what the new tool is helping them accomplish.  If there are competing brands of the tool on the market, I'm never surprised when they choose a different brand because that brand has re-engineered the tool to makes it even better.  Duke University buying a second unit tells me VPT is not only useful, it's the best option on the market. Sure. MAYO may feel a competing brand is better, but my guess is if the technicians at Duke feel VPT is the best and worth buying two, that many others will be taking notice and it won't be long before this gets going.  Especially when insurance companies start dictating the level of care. Insurance companies may start insisting on VPT before sending the patient for an MRI.  This should be hovering around .50 and head to a dollar so don't be surprised if it's spring loaded and it shoots past both those targets without giving us a chance to collect.  Just my opinion and I admit. I'm biased and waiting for 2025.
<< Previous
Bullboard Posts
Next >>